Tempus AI (NASDAQ:TEM) Given New $55.00 Price Target at Piper Sandler

Tempus AI (NASDAQ:TEM) had its price objective dropped by research analysts at Piper Sandler from $70.00 to $55.00 in a research report issued to clients and investors on Tuesday,Benzinga reports. The firm presently has a “neutral” rating on the stock. Piper Sandler’s target price suggests a potential upside of 10.60% from the company’s current price.

Other research analysts also recently issued research reports about the stock. Guggenheim reiterated a “buy” rating on shares of Tempus AI in a research report on Tuesday, February 25th. Wolfe Research lowered Tempus AI from a “strong-buy” rating to a “hold” rating in a report on Wednesday, February 26th. William Blair reaffirmed a “market perform” rating on shares of Tempus AI in a research note on Tuesday, February 25th. Needham & Company LLC upped their price objective on shares of Tempus AI from $56.00 to $70.00 and gave the stock a “buy” rating in a research report on Tuesday, February 25th. Finally, Loop Capital reduced their target price on shares of Tempus AI from $57.00 to $52.00 and set a “buy” rating for the company in a research report on Tuesday, January 14th. Six investment analysts have rated the stock with a hold rating and six have given a buy rating to the company. According to data from MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and a consensus target price of $59.73.

Tempus AI Trading Down 2.4 %

Shares of TEM traded down $1.20 during mid-day trading on Tuesday, reaching $49.73. The company had a trading volume of 6,940,733 shares, compared to its average volume of 4,656,446. The stock has a 50 day moving average of $53.02 and a two-hundred day moving average of $52.55. The company has a quick ratio of 2.55, a current ratio of 2.69 and a debt-to-equity ratio of 8.17. Tempus AI has a 52-week low of $22.89 and a 52-week high of $91.45.

Insider Transactions at Tempus AI

In related news, major shareholder Bradley A. Keywell sold 395,800 shares of the stock in a transaction on Wednesday, December 11th. The shares were sold at an average price of $42.95, for a total transaction of $16,999,610.00. Following the completion of the sale, the insider now owns 16,164,449 shares in the company, valued at $694,263,084.55. This represents a 2.39 % decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. Also, CEO Eric P. Lefkofsky sold 3,240,234 shares of the company’s stock in a transaction that occurred on Thursday, February 27th. The shares were sold at an average price of $58.75, for a total value of $190,363,747.50. Following the sale, the chief executive officer now directly owns 4,895,589 shares of the company’s stock, valued at approximately $287,615,853.75. This represents a 39.83 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold a total of 5,823,701 shares of company stock worth $320,906,059 over the last ninety days.

Institutional Inflows and Outflows

A number of institutional investors and hedge funds have recently bought and sold shares of the business. Wells Fargo & Company MN grew its holdings in shares of Tempus AI by 13.2% in the 4th quarter. Wells Fargo & Company MN now owns 2,384 shares of the company’s stock worth $80,000 after acquiring an additional 278 shares during the period. First Horizon Advisors Inc. purchased a new stake in shares of Tempus AI in the third quarter valued at about $30,000. Geode Capital Management LLC increased its stake in shares of Tempus AI by 0.4% during the 3rd quarter. Geode Capital Management LLC now owns 133,171 shares of the company’s stock worth $7,537,000 after purchasing an additional 539 shares in the last quarter. Operose Advisors LLC acquired a new position in shares of Tempus AI during the 4th quarter worth approximately $25,000. Finally, Prestige Wealth Management Group LLC lifted its stake in Tempus AI by 910.4% in the 4th quarter. Prestige Wealth Management Group LLC now owns 1,071 shares of the company’s stock valued at $36,000 after buying an additional 965 shares in the last quarter. Institutional investors and hedge funds own 24.22% of the company’s stock.

About Tempus AI

Tempus AI Inc is a technology company advancing precision medicine through the practical application of artificial intelligence principally in healthcare. The company provides AI-enabled precision medicine solutions to physicians to deliver personalized patient care and in parallel facilitates discovery, development and delivery of optimal therapeutics.